SCHEMBL1995323

SCHEMBL1995323

CN1CCOC(Cn2nc(C3=C(c4c[nH]c5sccc45)C(=O)NC3=O)c3ccccc32)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 3/20 0.46
PRKCB P05771 12/20 0.43
PRKCA P17252 12/20 0.43
PRKCG P05129 10/20 0.43
PRKCD Q05655 8/20 0.43
PRKCH P24723 6/20 0.43
PRKACA P17612 3/20 0.41
PRKACB P22694 2/20 0.41
PRKACG P22612 1/20 0.41
GSK3B P49841 14/20 0.40
KCNH2 Q12809 2/20 0.40
PRKCE Q02156 6/20 0.38
PRKCQ Q04759 4/20 0.38
PRKCZ Q05513 3/20 0.38
PIM1 P11309 3/20 0.38
CLK2 P49760 3/20 0.38
GSK3A P49840 3/20 0.38
RPS6KA3 P51812 3/20 0.38
JAK3 P52333 3/20 0.38
TAOK1 Q7L7X3 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990920 0.88 CAMK2D (0.47) CAMK2DPRKCBPRKCAPRKCGPRKCD
SCHEMBL1996421 0.88 CAMK2D (0.50) CAMK2DPRKCBPRKCAPRKCGPRKCD
SCHEMBL1992218 0.86 CAMK2D (0.49) CAMK2DPRKCBPRKCAPRKCGPRKCD
SCHEMBL1994915 0.86 PRKACA (0.55) CAMK2DPRKCBPRKCAPRKCGPRKCD
SCHEMBL1996935 0.86 CAMK2D (0.45) CAMK2DPRKCBPRKCAPRKCGPRKCD
SCHEMBL1989905 0.85 PRKACA (0.55) CAMK2DPRKCBPRKCAPRKCGPRKCD
SCHEMBL1990379 0.84 CAMK2D (0.45) CAMK2DPRKCBPRKCAPRKCGPRKCD
SCHEMBL1998189 0.84 CAMK2D (0.45) CAMK2DPRKCBPRKCAPRKCGPRKCD
SCHEMBL1993511 0.82 CAMK2D (0.45) CAMK2DPRKCBPRKCAPRKCGPRKCD
SCHEMBL1990076 0.81 CAMK2D (0.48) CAMK2DPRKCBPRKCAPRKCGPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO CAMK2D 2963/4885PRKCB 3335/4885PRKCA 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.